ArticleBMJ case reports2025
Valve-in-valve transcatheter aortic valve implantation in a patient with residual chronic type A aortic dissection.
Article in BMJ case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcatheter aortic valve implantation (TAVI) is a viable treatment of choice in patients with severe aortic stenosis across a wide spectrum of surgical risks (inoperable-high-moderate-low risk). Valve-in-valve (ViV) TAVI has emerged as a valid treatment option in patients with failed aortic bioprosthetic valves, especially in those with intermediate, high or prohibitive risk of surgery.ViV TAVI in patients with prior surgical bioprosthesis presents significant challenges, particularly in cases with stentless valves or radiolucent posts. Therefore, adequate pre-procedural planning is of utmost importance to its success. However, our case had multiple challenges that had to be overcome, including radiolucent posts, residual chronic type A aortic dissection flap in the non-coronary cusp and large body habitus with Killip class IV. Having successfully navigated the above challenges, we report this interesting and complex case of ViV TAVI which was a procedural success associated with significant improvement and recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.